長園集團(600525.SH):2024年員工持股計劃已完成公司股票購買
格隆匯3月31日丨長園集團(600525.SH)公佈,截至2025年3月31日,公司2024年員工持股計劃已完成公司股票購買,於二級市場通過集中競價交易方式購買公司A股股票合計2,143.6731萬股,佔公司總股本比例爲1.63%,成交總金額爲人民幣12,293.97萬元,成交均價5.735元/股。根據公司《2024年員工持股計劃》,2024年員工持股計劃的存續期爲36個月,所獲標的股票的鎖定期爲12個月,自員工持股計劃草案經公司股東大會審議通過且公司公告最後一筆標的股票購買完成之日起計算,即鎖定期爲2025年4月1日至2026年3月31日,鎖定期屆滿後一次性解鎖,解鎖比例爲100%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.